MIGRAINE UPDATE. Objectives & Disclosures. Learn techniques used to diagnose headaches. Become familiar with medications used for headache treatment.

Similar documents
Faculty Disclosure. Karen L. Bremer, MD. Dr. Bremer has listed no financial interest/arrangement that would be considered a conflict of interest.

How do we treat migraine? New SIGN Guidelines

HMFP Comprehensive Headache Center Department of Anesthesia, Critical Care and Pain Medicine Beth Israel Deaconess Medical Center Instructor in

A case of a patient with chronic headache. Focus on Migraine. None related to the presentation Grants to conduct clinical trials from: Speaker bureau:

Strategies in Migraine Care

OH, MY ACHING HEAD! I HAVE NO DISCLOSURES OR CONFLICTS OF INTERESTS TO DECLARE MANAGING HEADACHE IN THE OUTPATIENT SETTING SECONDARY HEADACHES

Headache. Section 1. Migraine headache. Clinical presentation

Tears of Pain SUNCT and SUNA A/PROFESSOR ARUN AGGARWAL RPAH PAIN MANAGEMENT CENTRE

Outpatient Headache Care Guideline

A synopsis of: Diagnosis and Management of Headaches in Adults: A national clinical guideline. Scottish intercollegiate Guidelines Network SIGN

Update on Diagnosis and Management of Migraines

Case Presentation. Case Presentation. Case Presentation. Truths about Headaches (2017) Most headaches were muscle-tension headaches

Clinical Learning Days November 10, 2017

ADVANCES IN MIGRAINE MANAGEMENT

Chronic Daily Headaches

Page: 1 of 6. Aimovig (erenumab-aooe) injection, Ajovy (fremanezumab-vfrm) injection, Emgality (galcanezumab-gnim)

Treatments for migraine

Disclosures. Triptans for Kids 5/16/13

Headache A Practical Approach

Anti-Migraine Agents

Headaches in the Pediatric Emergency Dept

Controlling Migraine Pain

Daniel Kassicieh, DO, FAAN

Headache Mary D. Hughes, MD Neuroscience Associates

Current Migraine Treatment Therapy. Daniel Kassicieh, DO, FAAN

Headache Questionnaire

Migraine Management. Jane Melling Headache nurse Mater Misericordiae Hospital

Index. Prim Care Clin Office Pract 31 (2004) Note: Page numbers of article titles are in boldface type.

10/31/2017 PRIMARY CARE AND HEADACHE DISCLOSURES WHERE DO THOSE WITH HEADACHE SEEK MEDICAL CARE? Primary Care 67%

Management of headache

Regulatory Status FDA approved indication: Migranal Nasal Spray is indicated for the acute treatment of migraine headaches with or without aura (1).

I have no financial relationships to disclose. I will not discuss investigational use of medication in my presentation.

Treatment of Primary Headache Syndromes

Faculty Disclosures. Learning Objectives. Acute Treatment Strategies

HEADACHE: Benign or Severe Dr Gobinda Chandra Roy

ONZETRA XSAIL (sumatriptan) nasal powder

Goals. Primary Headache Syndromes. One-Year Prevalence of Common Headache Disorders

COLUMBIA UNIVERSITY HEADACHE CENTER: NEW PATIENT QUESTIONNAIRE

Migraine, Tension, and Cluster Headache: Primary Care for Primary Headaches. Jonathon M. Firnhaber, MD, FAAFP

SUMAVEL DOSEPRO (sumatriptan succinate) solution for injection

Headache and Facial Pain. Mohammed ALEssa MBBS, FRCSC Assistant Professor Consultant Otolaryngology,Head & Neck Surgical Oncology

Clinical case. Clinical case 3/15/2018 OVERVIEW. Refractory headaches and update on novel treatment. Refractory headache.

ปวดศ รษะมา 5 ป ก นยาแก ปวดก ย งไม ข น นพ.พาว ฒ เมฆว ช ย โรงพยาบาลนครราชส มา

HEADACHE. Dr Nick Pendleton. September Headache

Adult & Pediatric Patients. Stanford Health Care, Division Pain Medicine

Headache Syndrome. Karen Alvarez, D.O Nemours Children s Specialty Care Jacksonville, FL

Headache Assessment In Primary Eye Care

ABORTIVE AGENTS. Average cost per 30 days. Form Limits SEROTONIN AGONISTS $ $ Reserved for treatment failure to either Sumatriptan PA; QL

Triptan Quantity Limit

25/09/2018 HEADACHE. Dr Nick Pendleton

Medication For Migraine Chart: Table 1: Acute Treatment when the attack begins

WHY IS MIGRAINE IMPORTANT

Headache Master School Japan-Osaka 2016 II. Management of refractory headaches Case Presentation 2. SUNCT/SUNA: concept, management and prognosis

Headache. Headache Case. Migraine Headache. Eric Kraus, MD. Types» Without aura (common)» With aura (classic)

What is new in the migraine world! Modar Khalil Consultant neurologist Hull Royal Infirmary

1. On how many days in the last 3 months did you miss work or school because of your headaches?

Migraine: Past, Present and Future Edward O Sullivan September 12 th 2015 Dublin 12/09/2015

Prevention and Treatment of Migraines CAITLIN BARNES, PHARM.D. CANDIDATE AMBULATORY CARE JOE CAMMILLERI, PHARM.D. NATOHYA MALLORY, PHARM.D.

By Nathan Hall Associate Editor

Pediatric Grand Rounds UT Health San Antonio 2/10/2017

Headache Dr. Asghari Neurologist

MEASURE #3: PREVENTIVE MIGRAINE MEDICATION PRESCRIBED Headache

Zomig. Zomig / Zomig-ZMT (zolmitriptan) Description

Adult with headache. Problem-specific video guides to diagnosing patients and helping them with management and prevention

SIGN on the pharmacological management of migraine

11. HEADACHE 1. Pablo Lapuerta, MD, Steven Asch, MD, MPH, and Kenneth Clark, MD, MPH

What You Should Know About Your HEADACHE. Learn more about headache types, triggers, and treatments, when to get help, and how to help yourself

July 2012 Target Population. Adult patients 18 years or older in primary care settings.

Maxalt. Maxalt / Maxalt-MLT (rizatriptan) Description. Section: Prescription Drugs Effective Date: April 1, 2016

MIGRAINE A MYSTERY HEADACHE

Managing Migraine: Primary Care for Primary Headaches

Subject: CGRP Inhibitors

Çiçek Wöber-Bingöl HEADACHE UNIT FOR CHILDREN AND ADOLESCENCE

Migranal Nasal Spray. Migranal Nasal Spray (dihydroergotamine) Description

Migraine Migraine Age Specific Prevalence in the United States. Headache International Headache Society Classification

Short Clinical Guidelines: Headache, Key Points for Diagnosis and Treatment

Migraine Management. Dr Helen Brown Director of Neurology and Stroke The Princess Alexandra Hospital

Emerging Challenges in Primary Care: Brainstorm: A Symposium on Migraine Treatment and Management

Headache evaluation and management after concussion. Assistant Professor

Vestibular Migraine. Information for patients and carers. Department of Neurology and Otolaryngology Aberdeen Royal Infirmary

The Pediatric Headache Handbook

Headaches. Mini Medical School. November 10, A. Laine Green MSc, MD FRCP(C) Assistant Professor Department of Medicine (Neurology)

Common Headaches. Types and Natural Treatments

The best defense is a good offense. Optimizing the Acute Treatment of Migraine. Disclosures 11/10/2017

Understanding. Migraine. Amy, diagnosed in 1989, with her family.

Chronic Migraine in Primary Care. December 11 th, 2017 Werner J. Becker University of Calgary

Corporate Medical Policy

Pharmacy Medical Necessity Guidelines: Migraine Medications

Management options for Migraine. Prof. Dr. Khwaja Nazimuddin Head Dept. of Internal Medicine BIRDEM

Differential Diagnosis of Headaches

10/17/2017 CHRONIC MIGRAINES BOTOX: TO INJECT OR NOT INJECT? IN CHRONIC MIGRAINE PROPHYLAXIS OBJECTIVES PATIENT CASE EPIDEMIOLOGY EPIDEMIOLOGY

How could I be having migraine when I don't have a headache?

Paediatric headaches. Dr Jaycen Cruickshank Director of Clinical Training Ballarat Health Services. Brevity, levity, repetition

CHRONIC HEADACHES IN CHILDHOOD

Clinical Policy: Triptans Reference Number: CP.CPA.217 Effective Date: Last Review Date: Line of Business: Commercial

Disclosures. Objectives 6/2/2017

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Headaches in Pregnancy Before, During, and After

Neurological Dilemmas in Primary Care

*** Drug Safety Alert ***

Transcription:

MIGRAINE UPDATE Karen L. Bremer, MD November 16, 2018 Objectives & Disclosures Learn techniques used to diagnose headaches. Become familiar with medications used for headache treatment. Disclosure: I am a paid speaker for Amgen/Novardis. 1

Common Causes of Headache Primary headache Pain for the sake of pain. Migraine Tension Ice-pick (brain freeze) Cluster Secondary headache Pain due to another cause: Infection (flu) Head injury (concussion) Bleeding in the brain or stroke Tumor Headache History Where is your headache (pain) located? Does the pain spread? How and when did it start? What is the pain like? Is it throbbing, stabbing, shooting, pressure, aching? When you have a headache, do you have sensitivity to light or sound? Are you nauseated? Do you have fever or chills? When did you start having headaches? How often do you have headaches? How long do your headaches usually last? What makes your headache better? What have you tried for your headaches? What makes your headaches worse? Movement Light Sound Bending over What triggers your headaches? Weather changes Stress Foods Odors Lack of sleep How severe is your pain, on a scale from 0-10? 2

Headache Examination Head and neck Pupils, fundoscopic exam, eye movements Palpate the area of pain Cranial nerves Carotid auscultation (for bruits) Neurological exam Strength, reflexes, coordination, sensation International Headache Society Classification of Headache Disorders IIIB International Headache Society (IHS) Criteria for primary Headaches Migraine without aura (Common) 5 attacks duration: 4-72 hours At least 2: unilateral, pulsating, moderate or severe, aggravation by activity At least 1: Nausea and/or vomiting Photophobia and phonophobia Symptoms are not suggestive of secondary headache. 3

International Headache Society Classification of Headache Disorders IIIB International Headache Society (IHS) Criteria for primary Headaches Migraine with aura At least 2 attacks One or more fully reversible aura symptom At least 3 of the following: develops gradually over 5 minutes or more 2 or more aura symptoms occur in succession Each individual aura symptom lasts 5-16 minutes At least one aura symptom is unilateral At least one aura symptom is positive The aura is accompanied or followed within 60 minutes by a headache Symptoms are not accounted by another headache disorder. 4

Migraine Aura vs. TIA AURA TIA Positive visual symptoms gradual onset/evolution sequential progression repetitive attacks of identical nature flurry of attacks mid-life duration: 20 minutes headache follows 50% Visual loss abrupt simultaneous duration <15 minutes headache uncommon 5

Migraine Aura International Headache Society Classification of Headache Disorders IIIB IHS Cluster headaches At least 5 attacks severe, unilateral orbital, supraorbital, and/or temporal pain lasting 15-180 minutes. Associated with at least one ipsilateral sign: Conjunctival injection, lacrimation, nasal congestion, rhinorrhea, forehead and facial sweating, meiosis, ptosis, eyelid edema Frequency: 1 every-other-day to 8 per day No suggestion of organic headache. May be precipitated by alcohol 6

Diagnostic testing: neuroimaging and lumbar puncture In patients with recurrent migraine, neither CT nor MRI is warranted except in cases where: recent substantial change in headache pattern history of seizures focal neurological symptoms or signs Lumbar puncture is indicated in the following circumstances: the first unusually severe headache thunderclap headache with negative CT head subacute progressive headache headache associated with fever, confusion, possible meningitis, or seizures high or low spinal pressure suspected (even if papilledema is absent) Treatment options: Acute pain First-line agents Triptans Sumatriptan, Rizatriptan, Almotriptan, Naratriptan, Zolmatriptan, Eletriptan, Frovatriptan Dihydroergotamine (DHE) Combination analgesics (ASA/caffeine/acetaminophen, and others) NSAIDS Naproxen, Ibuprofen 7

Triptans - Serotonin 5HT 1b/1d receptor agonists Indicated for use in migraine headache. Use limited to about 6-9 per month. Expensive (except for generic forms) Indicated for migraine but may have benefit for other headache types Contraindicated in uncontrolled hypertension, heart disease, stroke. Sumatriptan: 25, 50, 100 mg PO, 5&20 mg nasal, and 6 mg SQ Rizatriptan 5, 10 mg PO + MLT. Naratriptan 1, 2.5 mg PO Zolmitriptan 2.5, 5 mg PO + ZMT + Nasal. Eletriptan (Relpax) 20, 40 mg PO Almotriptan (Axert) 6.25,12.5 mg PO Frovatriptan (Frova) 1, 2 mg PO Ergotamines Historically useful in migraine headache. Less selective receptor action. More side-effects (nausea) Same contra-indications as for triptans. DHE-45 (dihydroergotamine) still used (intra-nasal) for migraine. 8

Combination analgesics Many over-the-counter (OTC) and prescription (Rx) preparations available. Effective for mild-moderate migraine. Inexpensive. Tell your doctor if you are taking any of these. Risk of overuse. Recommend limiting use to less than 10 doses per month. If using more than once per week, recommend adding on a preventive. NSAIDs Over-the-counter and Rx available, multiple brands and generics. Ketorolac very effective but usually administered as a shot in the emergency room or clinic. Diclofenac 50 mg powder FDA approved for migraine OTC and Rx (naproxen/ibuprofen) effective for mildmoderate migraine and used in combination with triptans for moderate to severe migraines. 9

Adjunctive agents Anti-nausea medications Promethazine Ondansetron Metoclopramide Anti-cholinergics (promote sleep and decrease side-effects of other medications) Diphenhydramine Benztropine Anti-anxiety medications Diazepam Narcotics (high risk of overuse) avoid Treatment Options: prevention First-line agents Amitriptyline Propranolol Valproic acid Topiramate Verapamil Candesartan Chronic migraine Onobotulinumtoxin A New meds: CGRP antagonists Herbal therapies Magnesium 400 mg BID Riboflavin 400 mg daily (AM) CoEnzyme Q10 (100 TID) Butterbur Feverfew Other: Sphenocath Occipital nerve block Capsaicin nasal spray Cefaly device Gammacore device 10

Preventive agents: ---------------- Decrease frequency/severity of migraine Tricyclic antidepressants Amitriptyline Nortriptyline Aim for 50% reduction (it s no cure). Start with very small dose (10 mg) and increase slowly. Common side-effects are drowsiness, dry mouth. Preventive agents: ------------------ Decrease frequency/severity of migraine heart or blood pressure medications Beta Blockers Use centrally acting agents. Propranolol and atenolol are preferred. Low dose Can make patients light-headed, depressed. Calcium Channel Blockers Verapamil used less than other agents listed here. Angiotensin Receptor Blockers Candesartan found recently to be effective for migraine prevention. 11

Preventive agents: ------------------ Decrease frequency/severity of migraine Anti-seizure medications Valproate Not for use in women who may get pregnant. Can cause weight gain, tremors, hair loss, liver enzyme elevations, decreased platelets. Topiramate Not for use in women who may get pregnant. Can cause weight loss, tingling in the feet and hands, kidney stones. Preventive agents Botox Indicated for treatment of chronic migraine headache (CM). CM = headaches more than 15 days per month lasting >4 hours per day More than 8 of these must be migraine headaches Expensive (@$2000 per treatment). Covered by insurance. Prior-authorization recommended. Benefits: when effective, decreases frequency and/or severity of migraine 50%. Risks: Expensive and may not work Pain at injection sites Ptosis (droopy eye) Nausea Dry mouth 12

Botox injection sites ----------- CGRP antagonists Monoclonal antibodies target and block the CGRP system (calcitonin gene related peptide). Erenumab targets the receptor. F and G target the CGRP molecule. All given by self-administered sub-q doses In order of FDA approval: Erenumab aooe - monthly Fremanezumab vfrm monthly after initial loading dose Galcanezumab gnlm monthly or every 3 months. Letters after generic name refer to the original molecule (biologic) to differentiate from generic products which may come later. Prescribed through specialty or home pharmacy after prior authorization approval. 13

Conclusion: Migraine diagnosis is made clinically. Start keeping a headache diary. There is no test to confirm a diagnosis of migraine headache. Lots of migraine and headache treatments are available. 14